Pancreatic Cancer Research

ResearcherOregon Health & Science UniversityActive in the last 2 years

Patrick Joseph Worth

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9600-0678; OpenAlex author ID A5027105177. Sources: ClinicalTrials.gov.

Their work

Papers
7 (first author 1, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper, 1 trial · 2025: 4 papers · 2026: 1 paper

Papers 7

  1. Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming in subtype-intermediate progenitor cells Co-author DOI 10.64898/2026.09.28.754674↗
  2. Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer. Co-author DOI 10.1038/s43018-024-00881-3↗
  3. Myc and Kras cooperate in adult acinar cells to drive phenotypic heterogeneity, metastasis, and therapeutic resistance in a novel pancreatic cancer mouse model First author DOI 10.1101/2025.07.14.664767↗
  4. MicroCT Enables Simultaneous Longitudinal Tracking of Murine Pancreatic Cancer Progression and Cachexia. Co-author DOI 10.1158/2767-9764.crc-25-0414↗
  5. A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathway Co-author DOI 10.64898/2025.12.12.693851↗
  6. Rapid metastatic recurrence after pancreatic cancer resection: a multi-center, regional analysis of trends in surgical failure over two decades. Last author DOI 10.1016/j.hpb.2024.08.006↗
  7. MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance. Co-author DOI 10.1038/s41467-017-01967-6↗

Trials 1

  1. Use Of Indocyanine Green In Pancreas Surgery Principal investigator NCT06084013↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rosalie C. Sears · 6 shared papers, 2017–2026 · strength 1.04
  2. Jonathan Robert Brody · 4 shared papers, 2025 · strength 0.74
  3. Motoyuki Tsuda · 4 shared papers, 2025–2026 · strength 0.74
  4. Brett C. Sheppard · 4 shared papers, 2017–2026 · strength 0.67
  5. Jason M. Link · 4 shared papers, 2017–2026 · strength 0.61
  6. Kevin Hawthorne · 3 shared papers, 2025–2026 · strength 0.58
  7. Ellen M. Langer · 3 shared papers, 2025–2026 · strength 0.58
  8. Lisa M. Coussens · 3 shared papers, 2025 · strength 0.49
  9. Isabel A. English · 3 shared papers, 2025 · strength 0.49
  10. Katherine R. Pelz · 2 shared papers, 2025 · strength 0.43
  11. Ethan S. Agritelley · 2 shared papers, 2025–2026 · strength 0.40
  12. Terry K. Morgan · 2 shared papers, 2025 · strength 0.33
  13. Katie E. Blise · 2 shared papers, 2025 · strength 0.33
  14. Gordon Brent Mills · 2 shared papers, 2025 · strength 0.31
  15. Adel Kardosh · 2 shared papers, 2025 · strength 0.31
  16. Charles D. Lopez · 2 shared papers, 2025 · strength 0.31
  17. Teresa A Zimmers · 1 shared paper, 2025 · strength 0.26
  18. Meghan M. Joly · 2 shared papers, 2017–2025 · strength 0.22
  19. Amy S. Farrell · 2 shared papers, 2017–2025 · strength 0.22
  20. Brittany L. Allen-Petersen · 2 shared papers, 2017–2025 · strength 0.22
  21. Pavlos Papavasiliou · 1 shared paper, 2024 · strength 0.21
  22. Thomas Lee Sutton · 1 shared paper, 2024 · strength 0.21
  23. Flavio G. Rocha · 1 shared paper, 2024 · strength 0.21
  24. Ranish K. Patel · 1 shared paper, 2024 · strength 0.21
  25. Laura DeLong Wood · 1 shared paper, 2025 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.